You are here

Article info

Article menu

Download PDFPDF

XML
Recent advances in clinical practice
Immunotherapy for advanced hepatocellular carcinoma: a focus on special subgroups

Authors

  • Matthias Pinter Division of Gastroenterology & Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria Liver Cancer (HCC) Study Group Vienna, Medical University of Vienna, Vienna, Austria PubMed articlesGoogle scholar articles
  • Bernhard Scheiner Division of Gastroenterology & Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria Liver Cancer (HCC) Study Group Vienna, Medical University of Vienna, Vienna, Austria PubMed articlesGoogle scholar articles
  • Markus Peck-Radosavljevic Department of Internal Medicine and Gastroenterology (IMuG), Hepatology, Endocrinology, Rheumatology and Nephrology including Centralized Emergency Department (ZAE), Klinikum Klagenfurt am Worthersee, Klagenfurt, Kärnten, Austria PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Matthias Pinter, Division of Gastroenterology & Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, A-1090, Austria; matthias.pinter{at}meduniwien.ac.at
View Full Text

Citation

Pinter M, Scheiner B, Peck-Radosavljevic M
Immunotherapy for advanced hepatocellular carcinoma: a focus on special subgroups
Gut 2021;70:204-214.

Publication history

  • Received May 4, 2020
  • Revised May 27, 2020
  • Accepted June 13, 2020
  • First published August 3, 2020.
Online issue publication 
December 09, 2020

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.